The Impact of Sarcopenia on Elderly Cancer Patients
Open Access
- 31 August 2017
- journal article
- Published by Peertechz Publications Private Limited
- Vol. 2 (1), 003-009
- https://doi.org/10.17352/aggr.000005
Abstract
No abstract availableThis publication has 52 references indexed in Scilit:
- Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinomaBritish Journal of Surgery, 2013
- The Prevalence of Sarcopenia in Patients With Respiratory Failure Classified as Normally Nourished Using Computed Tomography and Subjective Global AssessmentJournal of Parenteral and Enteral Nutrition, 2013
- Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular CarcinomaPLOS ONE, 2012
- Sarcopenia With Limited Mobility: An International ConsensusJournal of the American Medical Directors Association, 2011
- Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on SarcopeniaJournal of the American Medical Directors Association, 2011
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinomaAnnals of Oncology, 2010
- Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine TreatmentClinical Cancer Research, 2009
- Loss of skeletal muscle mass in aging: Examining the relationship of starvation, sarcopenia and cachexiaClinical Nutrition, 2007
- Body Composition as an Independent Determinant of 5-Fluorouracil–Based Chemotherapy ToxicityClinical Cancer Research, 2007